Cargando…

Adult pancreatoblastoma: A rare malignant tumor of the pancreas

Pancreatoblastoma (PB) is a rare malignant tumor in adults. It has an overall incidence of 0.004 per 100,000 inhabitants. Its diagnosis with fine-needle aspiration (FNA) is difficult due to multiple differentiation lines present on PB that overlap with other tumors. A 76-year-old male patient presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales, German Esteban Sánchez, Payan, Hillary Lizarraga, Valladares, Roberto Andre Moguel, Rosado, Ismael Domínguez, Chan, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Hepato-Biliary-Pancreatic Surgery 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382863/
https://www.ncbi.nlm.nih.gov/pubmed/34402449
http://dx.doi.org/10.14701/ahbps.2021.25.3.436
_version_ 1783741620303167488
author Morales, German Esteban Sánchez
Payan, Hillary Lizarraga
Valladares, Roberto Andre Moguel
Rosado, Ismael Domínguez
Chan, Carlos
author_facet Morales, German Esteban Sánchez
Payan, Hillary Lizarraga
Valladares, Roberto Andre Moguel
Rosado, Ismael Domínguez
Chan, Carlos
author_sort Morales, German Esteban Sánchez
collection PubMed
description Pancreatoblastoma (PB) is a rare malignant tumor in adults. It has an overall incidence of 0.004 per 100,000 inhabitants. Its diagnosis with fine-needle aspiration (FNA) is difficult due to multiple differentiation lines present on PB that overlap with other tumors. A 76-year-old male patient presented with jaundice, weight loss of 10 kg in 6 months, and appetite loss. Abdominal computed tomography scan showed a tumor in the pancreas head. Transendoscopic ultrasound with FNA biopsy revealed a malignant epithelial neoplasia compatible with PB with immunohistochemistry CK19 (+), P63(+), synaptophysin (–), and Ki67 50%. The patient underwent surgical resection and adjuvant chemotherapy. Currently, the patient is in follow-up with the latest imaging showing no evidence of disease at 32 months after his initial diagnosis. PB is an uncommon malignant neoplasia with an aggressive behavior. Its diagnostic and therapeutic protocols are unclear. Its preoperative diagnosis may be difficult since its imaging features and serological markers are non-specific. However, FNA may be useful in some situations. Surgical resection is currently the recommended treatment that is associated with the best long-term survival.
format Online
Article
Text
id pubmed-8382863
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Association of Hepato-Biliary-Pancreatic Surgery
record_format MEDLINE/PubMed
spelling pubmed-83828632021-09-04 Adult pancreatoblastoma: A rare malignant tumor of the pancreas Morales, German Esteban Sánchez Payan, Hillary Lizarraga Valladares, Roberto Andre Moguel Rosado, Ismael Domínguez Chan, Carlos Ann Hepatobiliary Pancreat Surg Case Report Pancreatoblastoma (PB) is a rare malignant tumor in adults. It has an overall incidence of 0.004 per 100,000 inhabitants. Its diagnosis with fine-needle aspiration (FNA) is difficult due to multiple differentiation lines present on PB that overlap with other tumors. A 76-year-old male patient presented with jaundice, weight loss of 10 kg in 6 months, and appetite loss. Abdominal computed tomography scan showed a tumor in the pancreas head. Transendoscopic ultrasound with FNA biopsy revealed a malignant epithelial neoplasia compatible with PB with immunohistochemistry CK19 (+), P63(+), synaptophysin (–), and Ki67 50%. The patient underwent surgical resection and adjuvant chemotherapy. Currently, the patient is in follow-up with the latest imaging showing no evidence of disease at 32 months after his initial diagnosis. PB is an uncommon malignant neoplasia with an aggressive behavior. Its diagnostic and therapeutic protocols are unclear. Its preoperative diagnosis may be difficult since its imaging features and serological markers are non-specific. However, FNA may be useful in some situations. Surgical resection is currently the recommended treatment that is associated with the best long-term survival. The Korean Association of Hepato-Biliary-Pancreatic Surgery 2021-08-31 2021-08-31 /pmc/articles/PMC8382863/ /pubmed/34402449 http://dx.doi.org/10.14701/ahbps.2021.25.3.436 Text en Copyright © 2021 by The Korean Association of Hepato-Biliary-Pancreatic Surgery https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Morales, German Esteban Sánchez
Payan, Hillary Lizarraga
Valladares, Roberto Andre Moguel
Rosado, Ismael Domínguez
Chan, Carlos
Adult pancreatoblastoma: A rare malignant tumor of the pancreas
title Adult pancreatoblastoma: A rare malignant tumor of the pancreas
title_full Adult pancreatoblastoma: A rare malignant tumor of the pancreas
title_fullStr Adult pancreatoblastoma: A rare malignant tumor of the pancreas
title_full_unstemmed Adult pancreatoblastoma: A rare malignant tumor of the pancreas
title_short Adult pancreatoblastoma: A rare malignant tumor of the pancreas
title_sort adult pancreatoblastoma: a rare malignant tumor of the pancreas
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382863/
https://www.ncbi.nlm.nih.gov/pubmed/34402449
http://dx.doi.org/10.14701/ahbps.2021.25.3.436
work_keys_str_mv AT moralesgermanestebansanchez adultpancreatoblastomaararemalignanttumorofthepancreas
AT payanhillarylizarraga adultpancreatoblastomaararemalignanttumorofthepancreas
AT valladaresrobertoandremoguel adultpancreatoblastomaararemalignanttumorofthepancreas
AT rosadoismaeldominguez adultpancreatoblastomaararemalignanttumorofthepancreas
AT chancarlos adultpancreatoblastomaararemalignanttumorofthepancreas